Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin

Clinical Microbiology and Infection

Volumn 12, Issue 2, 2006, Pages 197-198

  Fernández Cuenca, Felipe ^a   Martinez Martinez L ^a   Amblar, G ^a   Biedenbach, D J ^a   Jones, R N ^a   Pascual, A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CEFOXITIN; CLAVULANIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; ENZYME SYNTHESIS; ESCHERICHIA COLI; FREQUENCY ANALYSIS; GEOGRAPHIC DISTRIBUTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33644919147     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01315.x     Document Type: Letter

References (6)

1. Perez Moreno MO, Perez Moreno M, Carulla M, Rubio C, Jardi AM, Zaragoza J. Mechanisms of reduced susceptibility to amoxicillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain). Clin Microbiol Infect 2004; 10: 234-241.
2. Martinez-Martinez L, Conejo MC, Pascual A et al. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles. Antimicrob Agents Chemother 2000; 44: 2534-2536.
3. Clarke B, Hiltz M, Musgrave H, Forward KR. Cephamycin resistance in clinical isolates and laboratory-derived strains of Escherichia coli, Nova Scotia, Canada. Emerg Infect Dis 2003; 9: 1254-1259.
4. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th edn. Approved standard M7-A5. Wayne, PA: NCCLS, 2000.
5. Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 2004; 24: 585-591.
6. Jones RN, Jenkins SG, Hoban DJ, Pfaller MA, Ramphal R. In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated in 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program 1997-1998. Int J Antimicrob Agents 2000; 15: 111-118.